RedShiftBio is redefining the possibilities for structural characterization of biomolecules. RedShiftBio has developed a proprietary life sciences platform combining our Microfluidic Modulation Spectroscopy (MMS) and expertise in high powered quantum cascade lasers that provides ultra-sensitive and ultra-precise measurements of molecular structure. These structural changes affect critical quality attributes governing the safety, efficacy, and stability of biomolecules and their raw materials. This combination of technologies is available to researchers in our fully-automated AQS³pro Analyzer and is backed by a global network of sales, applications, service, and support teams to address all market needs. Led by an experienced management team with a proven track record of success in both large instrumentation companies and commercializing disruptive technologies, RedShiftBio is here to support your research and development goals. Our instruments can be found in the majority of the leading biopharmaceutical companies in the world.
Showing the single result
RedShiftBio’s AQS³pro overcomes many of the limitations of traditional spectroscopy-based technologies with ultrasensitive, highly reproducible, automated structural measurements of proteins and other biomolecules.
RedShiftBio’s AQS³pro overcomes many of the limitations of traditional spectroscopy-based technologies with ultrasensitive, highly reproducible, automated structural measurements of proteins and other biomolecules.
© DKSH International Ltd. All Rights Reserved.
test block for Laos
<iframe src=”https://contactmarketing.dksh.com/l/992242/2024-07-21/37w9k“>
Please enter your details here:
